Biblio

Export 309 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Keyword is T  [Clear All Filters]
Journal Article
H. - L. Sun, Zhou, F. - Y., Chen, D. - W., Tan, C. - R., Zeng, G. - H., Liu, Y. - H., Wang, J., Le Bu, X. -, Wang, Y. - J., Li, H. - Y., and Jin, W. - S., The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 85, no. 3, pp. 1321-1328, 2022.
M. Pacheco-Herrero, Soto-Rojas, L. O., Reyes-Sabater, H., Garcés-Ramirez, L., López, Fde la Cruz, Villanueva-Fierro, I., and Luna-Muñoz, J., Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease., J Alzheimers Dis, vol. 84, no. 3, pp. 917-935, 2021.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells., J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
J. Geng, Xia, L., Li, W., Zhao, C., and Dou, F., Cycloheximide Treatment Causes a ZVAD-Sensitive Protease-Dependent Cleavage of Human Tau in Drosophila Cells., J Alzheimers Dis, vol. 49, no. 4, pp. 1161-8, 2016.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia., J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
G. D'Onofrio, Panza, F., Sancarlo, D., Paris, F. F., Cascavilla, L., Mangiacotti, A., Lauriola, M., Paroni, G. H., Seripa, D., and Greco, A., Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach., J Alzheimers Dis, vol. 51, no. 2, pp. 427-37, 2016.
B. Tousi, Dementia Care in the Time of COVID-19 Pandemic., J Alzheimers Dis, vol. 76, no. 2, pp. 475-479, 2020.
A. Benaque, Gurruchaga, M. Jone, Abdelnour, C., Hernandez, I., Cañabate, P., Alegret, M., Rodríguez, I., Rosende-Roca, M., Tartari, J. Pablo, Esteban, E., López, R., Gil, S., Vargas, L., Mauleón, A., Espinosa, A., Ortega, G., Sanabria, Á., Pérez, A., Alarcón, E., González-Pérez, A., Marquié, M., Valero, S., Tárraga, L., Ruiz, A., and Boada, M., Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain., J Alzheimers Dis, vol. 76, no. 1, pp. 33-40, 2020.
A. D. Korczyn, Dementia in the COVID-19 Period., J Alzheimers Dis, vol. 75, no. 4, pp. 1071-1072, 2020.
M. Barbera, Mangialasche, F., Jongstra, S., Guillemont, J., Ngandu, T., Beishuizen, C., Coley, N., Brayne, C., Andrieu, S., Richard, E., Soininen, H., and Kivipelto, M., Designing an Internet-Based Multidomain Intervention for the Prevention of Cardiovascular Disease and Cognitive Impairment in Older Adults: The HATICE Trial., J Alzheimers Dis, vol. 62, no. 2, pp. 649-663, 2018.
D. Rizzuto, Feldman, A. L., Karlsson, I. K., Aslan, A. K. Dahl, Gatz, M., and Pedersen, N. L., Detection of Dementia Cases in Two Swedish Health Registers: A Validation Study., J Alzheimers Dis, vol. 61, no. 4, pp. 1301-1310, 2018.
Z. Liu, Kameshima, N., Nanjo, T., Shiino, A., Kato, T., Shimizu, S., Shimizu, T., Tanaka, S., Miura, K., and Tooyama, I., Development of a High-Sensitivity Method for the Measurement of Human Nasal Aβ42, Tau, and Phosphorylated Tau., J Alzheimers Dis, vol. 62, no. 2, pp. 737-744, 2018.
E. Niemantsverdriet, Goossens, J., Struyfs, H., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Vanderstichele, H., and Engelborghs, S., Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
O. Bousiges, Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin-Hunyadi, C., and Blanc, F., Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
B. G. Schreurs and D Sparks, L., Dietary high cholesterol and trace metals in the drinking water increase levels of ABCA1 in the rabbit hippocampus and temporal cortex., J Alzheimers Dis, vol. 49, no. 1, pp. 201-9, 2016.
S. Gelman, Palma, J., Tombaugh, G., and Ghavami, A., Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 195-208, 2018.
Z. - Q. Xu, Huang, H., Chen, Y. - L., Gao, Y. - Y., Xu, J., Marshall, C., Cai, Z. - Y., and Xiao, M., Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis., J Alzheimers Dis, vol. 51, no. 1, pp. 179-95, 2016.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid., J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein., J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
A. Dodich, Cerami, C., Crespi, C., Canessa, N., Lettieri, G., Iannaccone, S., Marcone, A., Cappa, S. F., and Cacioppo, J. T., Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 1011-22, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
J. Gustavo Villamil-Ortiz, Barrera-Ocampo, A., Arias-Londoño, J. David, Villegas, A., Lopera, F., and Cardona-Gómez, G. Patricia, Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains., J Alzheimers Dis, vol. 61, no. 1, pp. 209-219, 2018.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J., Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo., J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J., Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo., J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W., Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.

Pages